Another study uncovered the potential mechanism of TGR5 and FXR, suggesting that some BAs indirectly promote glucagon-like peptide-1 (GLP-1) secretion by activating TGR5 or FXR, thereby lowering blood glucose and providing a possible therapy for PCOS [77,78]. The gene discussed is NR1H4; the disease is polycystic ovary syndrome.